Supernus Pharmaceuticals (SUPN) FCF Margin (2011 - 2026)
Supernus Pharmaceuticals (SUPN) recorded FCF Margin of -2.46% in Q2 2026, down 37.56 percentage points from 35.10% a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) FCF Margin (2011 - 2026) Analysis & Trends
On a TTM basis, Supernus Pharmaceuticals' FCF Margin came in at 2.38% as of Jun 30, 2026, down 25.56 percentage points year-over-year; for FY2025, it came in at 6.40%, down 19.47 percentage points from FY2024.
- Annual FCF Margin has a five-year change of -19.53 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at 25.87% in FY2024 (+7.68 pp), 18.19% in FY2023 (+0.75 pp), 17.45% in FY2022 (-4.48 pp) and 21.93% in FY2021 (-4.01 pp).
- Quarterly FCF Margin has ranged from -32.17% in Q3 2025 to 42.16% in Q2 2022 over the past five years.
- On a year-over-year basis, FCF Margin rose in two of the last seven quarters, with an average year-over-year change of -14.79 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 35.17 percentage points in Q2 2024, against a drop of 62.52 percentage points in Q3 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn | -2.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.46% |
| Dec 31, 2025 | 9.19% |
| Sep 30, 2025 | -32.17% |
| Jun 30, 2025 | 35.10% |
| Mar 31, 2025 | 20.21% |
| Dec 31, 2024 | 25.38% |
| Sep 30, 2024 | 30.35% |
| Jun 30, 2024 | 21.13% |
| Mar 31, 2024 | 26.56% |
| Dec 31, 2023 | 27.38% |
| Sep 30, 2023 | 23.22% |
| Jun 30, 2023 | -14.04% |
| Mar 31, 2023 | 31.77% |
| Dec 31, 2022 | 16.48% |
| Sep 30, 2022 | 7.72% |
| Jun 30, 2022 | 42.16% |
| Mar 31, 2022 | 2.26% |
| Dec 31, 2021 | 30.66% |
| Sep 30, 2021 | -2.77% |
| Jun 30, 2021 | 32.74% |
API Access
Supernus Pharmaceuticals FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();